Millennium Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
927,558
+53,159
| +6% | +$605K | 0.01% | 1570 |
|
|
2025
Q1 | $10.4M | Buy |
874,399
+450,262
| +106% | +$5.35M | 0.01% | 1490 |
|
|
2024
Q4 | $7.99M | Buy |
424,137
+202,419
| +91% | +$3.81M | ﹤0.01% | 1720 |
|
|
2024
Q3 | $4.98M | Sell |
221,718
-377,905
| -63% | -$8.49M | ﹤0.01% | 1985 |
|
|
2024
Q2 | $12.5M | Buy |
599,623
+225,374
| +60% | +$4.7M | 0.01% | 1333 |
|
|
2024
Q1 | $5.5M | Sell |
374,249
-3,339
| -0.9% | -$49.1K | ﹤0.01% | 1906 |
|
|
2023
Q4 | $3.9M | Buy |
377,588
+89,431
| +31% | +$923K | ﹤0.01% | 2050 |
|
|
2023
Q3 | $2.26M | Sell |
288,157
-356,254
| -55% | -$2.8M | ﹤0.01% | 2395 |
|
|
2023
Q2 | $6.44M | Buy |
644,411
+182,819
| +40% | +$1.83M | ﹤0.01% | 1753 |
|
|
2023
Q1 | $4.1M | Sell |
461,592
-85,743
| -16% | -$761K | ﹤0.01% | 2057 |
|
|
2022
Q4 | $6.01M | Sell |
547,335
-192,590
| -26% | -$2.11M | ﹤0.01% | 1998 |
|
|
2022
Q3 | $9.64M | Sell |
739,925
-72,003
| -9% | -$938K | 0.01% | 1609 |
|
|
2022
Q2 | $10.3M | Buy |
811,928
+445,696
| +122% | +$5.65M | 0.01% | 1487 |
|
|
2022
Q1 | $5.13M | Sell |
366,232
-230,054
| -39% | -$3.22M | ﹤0.01% | 2265 |
|
|
2021
Q4 | $17.3M | Buy |
596,286
+359,403
| +152% | +$10.4M | 0.01% | 1117 |
|
|
2021
Q3 | $7.1M | Sell |
236,883
-189,103
| -44% | -$5.67M | ﹤0.01% | 1850 |
|
|
2021
Q2 | $11.3M | Buy |
425,986
+186,051
| +78% | +$4.94M | 0.01% | 1279 |
|
|
2021
Q1 | $7.46M | Buy |
239,935
+126,731
| +112% | +$3.94M | 0.01% | 1672 |
|
|
2020
Q4 | $3.72M | Buy |
+113,204
| New | +$3.72M | ﹤0.01% | 2112 |
|